Arnold Ventures: How A Philanthropy Helped Tip The Scales In US Drug Pricing Debate
A review of grants by the organization to a range of recipients engaged in work on lowering drug prices.
You may also be interested in...
Funded in part by Arnold Ventures, the NEJM study offers more data supporting the Rx industry’s call for 340B reform, and another perspective on how the savings could be used to benefit patients.
Patient advocates are optimistic that ‘historic bill’ establishing price negotiation, inflation rebates and a spending cap in Medicare will pass into law.
AHIP arrangement is a big win for ICER and will facilitate access to the organization’s cloud-based cost effectiveness review platform for a broad range of payers, particularly small and mid-size companies that may not have the resources to subscribe to the service on their own.